Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
Crunch: A New Protein Tool to Fight Cancer and Diseases
Research & Development Crunch: A New Protein Tool to Fight Cancer and Diseases

Imagine a world where the body’s own cleanup crew could be trained to target and eliminate harmful cells, such as those driving cancer or autoimmune disorders, with pinpoint accuracy. This isn’t a distant dream but a reality being shaped by groundbreaking research into a protein-based tool called

AI-Driven Natural Drug Design for Metabolic Diseases
Research & Development AI-Driven Natural Drug Design for Metabolic Diseases

In a world grappling with the escalating burden of metabolic diseases, innovative solutions are urgently needed to address conditions like type 2 diabetes, obesity, non-alcoholic fatty liver disease, and certain cancers, which collectively affect millions globally and strain healthcare systems.

Can AI Revolutionize Anticoagulation for Atrial Fibrillation?
Tech & Innovation Can AI Revolutionize Anticoagulation for Atrial Fibrillation?

This how-to guide aims to equip healthcare professionals, researchers, and interested individuals with a clear understanding of how artificial intelligence (AI) can transform anticoagulation therapy for patients with atrial fibrillation (AF). By following the structured steps outlined, readers will

Digital Twins Transform Clinical Trials with New Promise
Research & Development Digital Twins Transform Clinical Trials with New Promise

In an era where pharmaceutical innovation faces mounting pressure to deliver faster and more cost-effective solutions, digital twins have emerged as a groundbreaking force in reshaping clinical trials, offering a transformative approach to drug development. These virtual patient models, crafted

How Do Genomic Clues Reveal Early Multiple Myeloma Origins?
Research & Development How Do Genomic Clues Reveal Early Multiple Myeloma Origins?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a deep understanding of technology and innovation in the industry, has positioned him as a leading voice in cancer research. Today, we’ll dive into his

Can AI Revolutionize Drug Discovery with Natural Compounds?
Research & Development Can AI Revolutionize Drug Discovery with Natural Compounds?

In the fast-paced realm of healthcare innovation, a remarkable partnership between Singapore-based Nanyang Biologics (NYB), global digital infrastructure giant Equinix, and technology leader Hewlett Packard Enterprise (HPE) is capturing attention across the industry. This collaboration has given

FDA Approves Ajovy for Pediatric Migraine Prevention
Management & Regulatory FDA Approves Ajovy for Pediatric Migraine Prevention

Imagine a child unable to attend school or play with friends due to the throbbing pain of a migraine, a condition often dismissed as just a headache but capable of derailing young lives with symptoms like nausea and sensitivity to light. This debilitating neurological disorder affects roughly one

Baricitinib Safety Analysis in High-Risk Patient Groups
Research & Development Baricitinib Safety Analysis in High-Risk Patient Groups

In the rapidly evolving field of autoimmune disease treatment, Baricitinib, an oral Janus kinase (JAK) inhibitor, has carved out a significant role as a promising therapy for conditions such as rheumatoid arthritis and atopic dermatitis. For countless patients, particularly those in high-risk

New Blood Test Revolutionizes Early Ovarian Cancer Detection
Research & Development New Blood Test Revolutionizes Early Ovarian Cancer Detection

Imagine a world where a silent, deadly disease like ovarian cancer, which affects thousands of women each year, could be caught in its earliest stages with just a simple blood draw, offering hope for timely intervention. This devastating illness, often striking women over 50, frequently goes

How Is ASU's AI Robodog Revolutionizing Human Assistance?
Tech & Innovation How Is ASU's AI Robodog Revolutionizing Human Assistance?

Picture a world where a robotic dog doesn’t just wag a mechanical tail but steps into disaster zones to save lives or guides someone with visual impairment through a bustling city street, transforming the way we approach human assistance. At Arizona State University (ASU), this compelling vision is

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later